Concepedia

William Boreland

WB

Statistics

Publications

5

Citations

113

H-Index

5

Active since

2024

Affiliations

KU Leuven(Current)

Charité - Universitätsmedizin Berlin

European Society for Blood and Marrow Transplantation

First Pavlov State Medical University of St. Petersburg

University of Rijeka

William Boreland is an author at KU Leuven specializing in transplant outcomes, allogeneic stem cell transplantation, and allogeneic stem cell therapy.

ORCID

Publications per year

2024–2024

5

Publications

5

PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation

Olaf Penack, Mouad Abouqateb, Christophe Peczynski et al. · Blood Cancer Journal · 2024 · 43 citations · Full text

, , +16

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

Olaf Penack, Mouad Abouqateb, Christophe Peczynski et al. · Leukemia · 2024 · 32 citations · Full text

, , +16

How risky is a second allogeneic stem cell transplantation?

Olaf Penack, Mouad Abouqateb, Christophe Peczynski et al. · Leukemia · 2024 · 17 citations · Full text

, , +16

ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party

Olaf Penack, Christophe Peczynski, William Boreland et al. · Bone Marrow Transplantation · 2024 · 11 citations · Full text

, , +7

Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study

Guillermo Ortí, Christophe Peczynski, William Boreland et al. · Leukemia · 2024 · 10 citations · Full text

, , +17

1–5 of 5